(SPOK) Spok Holdings - Ratings and Ratios
Pager, Messaging, Alerting, Platform
Dividends
| Dividend Yield | 9.61% |
| Yield on Cost 5y | 19.78% |
| Yield CAGR 5y | 25.79% |
| Payout Consistency | 87.6% |
| Payout Ratio | 1.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.7% |
| Value at Risk 5%th | 46.6% |
| Relative Tail Risk | -10.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.49 |
| Alpha | -23.21 |
| CAGR/Max DD | 0.93 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | 0.424 |
| Beta Downside | 0.631 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.97% |
| Mean DD | 7.17% |
| Median DD | 5.02% |
Description: SPOK Spok Holdings October 26, 2025
Spok Holdings, Inc. (NASDAQ:SPOK) operates through its subsidiary Spok, Inc. to deliver a suite of healthcare communication solutions-including one-way and two-way messaging, alphanumeric pagers (GenA Pager), voicemail, and equipment protection services-across North America, Europe, Asia, Australia, and the Middle East. Its offerings target clinical workflow efficiency, administrative compliance, and real-time patient-care coordination for a broad customer base that spans hospitals, health systems, public-safety agencies, and various non-clinical enterprises.
Key metrics that shape Spok’s outlook include a FY 2023 revenue of approximately $78 million, with a year-over-year subscription-revenue growth rate of roughly 12%, reflecting the broader shift toward recurring-revenue models in digital health. The company’s annual churn rate hovers near 6%, while its EBITDA margin sits at 14%, indicating modest profitability relative to peers. Sector-wide, the demand for secure, HIPAA-compliant messaging is being driven by rising telehealth adoption (projected to grow >20% CAGR through 2028) and increasing regulatory pressure for real-time clinical alerts, both of which underpin Spok’s growth potential.
If you’re looking to benchmark SPOK’s valuation and risk profile against other wireless telecommunication and health-tech firms, ValueRay’s analytics platform provides a concise, data-rich comparison that can help inform your next research steps.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (16.6m TTM) > 0 and > 6% of Revenue (6% = 8.38m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -2.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.46% (prev 9.26%; Δ -1.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 25.8m > Net Income 16.6m (YES >=105%, WARN >=100%) |
| Net Debt (-14.0m) to EBITDA (26.5m) ratio: -0.53 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (21.0m) change vs 12m ago 2.42% (target <= -2.0% for YES) |
| Gross Margin 64.91% (prev 63.06%; Δ 1.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 65.54% (prev 63.53%; Δ 2.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 2.42
| (A) 0.05 = (Total Current Assets 59.5m - Total Current Liabilities 49.1m) / Total Assets 209.7m |
| (B) 0.21 = Retained Earnings (Balance) 43.7m / Total Assets 209.7m |
| (C) 0.10 = EBIT TTM 22.1m / Avg Total Assets 213.2m |
| (D) 0.69 = Book Value of Equity 41.9m / Total Liabilities 61.0m |
| Total Rating: 2.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.02
| 1. Piotroski 6.50pt |
| 2. FCF Yield 9.08% |
| 3. FCF Margin 16.19% |
| 4. Debt/Equity 0.05 |
| 5. Debt/Ebitda -0.53 |
| 6. ROIC - WACC (= 2.68)% |
| 7. RoE 10.95% |
| 8. Rev. Trend 36.21% |
| 9. EPS Trend 59.04% |
What is the price of SPOK shares?
Over the past week, the price has changed by -1.88%, over one month by -3.11%, over three months by -26.33% and over the past year by -13.59%.
Is SPOK a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SPOK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21 | 61.2% |
| Analysts Target Price | 21 | 61.2% |
| ValueRay Target Price | 15.8 | 21.3% |
SPOK Fundamental Data Overview November 26, 2025
P/E Trailing = 15.9625
P/S = 1.8824
P/B = 1.762
Beta = 0.4
Revenue TTM = 139.7m USD
EBIT TTM = 22.1m USD
EBITDA TTM = 26.5m USD
Long Term Debt = 7.36m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.74m USD (from shortTermDebt, last quarter)
Debt = 7.36m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -14.0m USD (from netDebt column, last quarter)
Enterprise Value = 249.0m USD (263.0m + Debt 7.36m - CCE 21.4m)
Interest Coverage Ratio = unknown (Ebit TTM 22.1m / Interest Expense TTM 0.0)
FCF Yield = 9.08% (FCF TTM 22.6m / Enterprise Value 249.0m)
FCF Margin = 16.19% (FCF TTM 22.6m / Revenue TTM 139.7m)
Net Margin = 11.88% (Net Income TTM 16.6m / Revenue TTM 139.7m)
Gross Margin = 64.91% ((Revenue TTM 139.7m - Cost of Revenue TTM 49.0m) / Revenue TTM)
Gross Margin QoQ = 78.27% (prev 60.54%)
Tobins Q-Ratio = 1.19 (Enterprise Value 249.0m / Total Assets 209.7m)
Interest Expense / Debt = 7.82% (Interest Expense 575.0k / Debt 7.36m)
Taxrate = 30.07% (1.38m / 4.58m)
NOPAT = 15.5m (EBIT 22.1m * (1 - 30.07%))
Current Ratio = 1.21 (Total Current Assets 59.5m / Total Current Liabilities 49.1m)
Debt / Equity = 0.05 (Debt 7.36m / totalStockholderEquity, last quarter 148.7m)
Debt / EBITDA = -0.53 (Net Debt -14.0m / EBITDA 26.5m)
Debt / FCF = -0.62 (Net Debt -14.0m / FCF TTM 22.6m)
Total Stockholder Equity = 151.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.92% (Net Income 16.6m / Total Assets 209.7m)
RoE = 10.95% (Net Income TTM 16.6m / Total Stockholder Equity 151.5m)
RoCE = 13.92% (EBIT 22.1m / Capital Employed (Equity 151.5m + L.T.Debt 7.36m))
RoIC = 10.20% (NOPAT 15.5m / Invested Capital 151.5m)
WACC = 7.52% (E(263.0m)/V(270.4m) * Re(7.58%) + D(7.36m)/V(270.4m) * Rd(7.82%) * (1-Tc(0.30)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.65%
[DCF Debug] Terminal Value 79.67% ; FCFE base≈25.2m ; Y1≈27.8m ; Y5≈36.0m
Fair Price DCF = 30.38 (DCF Value 625.7m / Shares Outstanding 20.6m; 5y FCF grow 12.05% → 3.0% )
EPS Correlation: 59.04 | EPS CAGR: 188.0% | SUE: -1.01 | # QB: 0
Revenue Correlation: 36.21 | Revenue CAGR: -0.53% | SUE: -0.61 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.83 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+3.8% | Growth Revenue=+2.6%
Additional Sources for SPOK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle